Hedge Fund - Baker Bros. Advisors
Revolution Medicines Inc. (RVMD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $753,119,185 | 4.41% | 9,455,357 | $65.57 |
| 2 | 2025 - Q3 (2025-09-30) | $441,565,172 | 3.19% | 9,455,357 | $39.15 |
| 3 | 2025 - Q2 (2025-06-30) | $344,537,320 | 3.34% | 9,364,972 | $38.42 |
| 4 | 2025 - Q1 (2025-03-31) | $280,651,330 | 3.11% | 7,936,972 | $40.59 |
| 5 | 2024 - Q4 (2024-12-31) | $347,163,155 | 3.7% | 7,936,972 | $50.47 |
| 6 | 2024 - Q3 (2024-09-30) | $343,258,232 | 3.55% | 7,569,090 | $43.54 |
| 7 | 2024 - Q2 (2024-06-30) | $293,756,383 | 3.75% | 7,569,090 | $37.38 |
| 8 | 2024 - Q1 (2024-03-31) | $243,312,295 | 3.05% | 7,549,249 | $29.64 |
| 9 | 2023 - Q4 (2023-12-31) | $147,663,483 | 1.68% | 5,148,657 | $24.03 |
| 10 | 2023 - Q3 (2023-09-30) | $74,500,526 | 0.42% | 2,691,493 | $29.66 |
| 11 | 2023 - Q2 (2023-06-30) | $71,997,438 | 0.41% | 2,691,493 | $24.54 |
| 12 | 2023 - Q1 (2023-03-31) | $58,297,738 | 0.31% | 2,691,493 | $24.62 |
| 13 | 2022 - Q4 (2022-12-31) | $5,293,328 | 0.03% | 222,222 | $21.26 |
| 14 | 2022 - Q3 (2022-09-30) | $4,382,000 | 0.02% | 222,222 | $21.98 |
| 15 | 2022 - Q2 (2022-06-30) | $4,331,000 | 0.02% | 222,222 | $19.47 |
| 16 | 2022 - Q1 (2022-03-31) | $5,669,000 | 0.03% | 222,222 | $21.77 |
| 17 | 2021 - Q4 (2021-12-31) | $5,593,000 | 0.02% | 222,222 | $28.18 |
| 18 | 2021 - Q3 (2021-09-30) | $6,113,000 | 0.02% | 222,222 | $29.11 |
| 19 | 2021 - Q2 (2021-06-30) | $7,053,000 | 0.03% | 222,222 | $34.90 |
| 20 | 2021 - Q1 (2021-03-31) | $10,196,000 | 0.04% | 222,222 | $44.84 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center